One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial
Patrick W. Serruys(Erasmus MC), Nicolas M. Van Mieghem(Erasmus MC), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Yosuke Miyazaki(Yamaguchi University), Neal S. Kleiman(Houston Methodist), Lars Søndergaard(University of Copenhagen), Rodrigo Modolo(Amsterdam UMC Location University of Amsterdam), Stephan Windecker(University of Bern), Piet W. Boonstra(Medisch Centrum Leeuwarden), Jeffrey J. Popma(Cardiovascular Research Foundation), Michael J. Reardon(Houston Methodist), Scott Lilly(The Ohio State University Wexner Medical Center), Yanping Chang(Medtronic (United States)), Hafid Amrane(Medisch Centrum Leeuwarden), A. Pieter Kappetein(Erasmus University Rotterdam)
Cited by 73
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k